Showing results (201-210 of 211) with videos related to
Sort By:
Pageof 22
Journal of the National Cancer Center|September 16, 2024
Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysisJingnan Wang, Xin Liu, Yunpeng Wu, et al.Journal of the National Cancer Center|September 16, 2024
The prognostic role of circulating tumor DNA across breast cancer molecular subtypes: A systematic review and meta-analysisNana Guo, Qingxin Zhou, Meng Zhang, et al.Journal of the National Cancer Center|September 16, 2024
Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapyYu Wang, Wenqing Wang, Tao Zhang, et al.Journal of the National Cancer Center|February 25, 2026
Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistanceShuai Gao, Nolan D Patten, Changmeng CaiJournal of the National Cancer Center|February 25, 2026
Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancerYujun Shuai, Haojie HuangJournal of the National Cancer Center|April 20, 2026
Exploring the genetic overlap between obstructive sleep apnea and prostate cancerAllan Saj Porcacchia, Mariana Moyses-Oliveira, Gabriel Natan Pires, et al.Journal of the National Cancer Center|June 12, 2026
Extracellular vesicles in prostate cancer: current understanding and future perspectivesBalaji Perumalsamy, Parthasarathy Seshacharyulu, Raghupathy Vengoji, et al.Journal of the National Cancer Center|June 12, 2026
MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohortLiuliu Quan, Shuyue Chen, Zixuan Yang, et al.Journal of the National Cancer Center|June 12, 2026
Female underrepresentation and adverse events reporting biases in lung cancer clinical trials: a systematic review and meta-analysisYena Gan, Rui Tian, Sheng Han, et al.Journal of the National Cancer Center|August 22, 2026
Circulating tumor DNA as a predictive biomarker for prognosis in hepatocellular carcinoma: a systematic review and meta-analysisMeng Zhang, Xiaowei Chen, Qingxin Zhou, et al.Pageof 22